{"0": {"ibrutinib": 0.6203896999359131, "refractory cll": 0.5721693634986877, "cll": 0.5540487766265869, "efficacy": 0.4489430785179138, "clinical": 0.43966084718704224, "treatment": 0.43470025062561035, "tg therapeutics": 0.3978580832481384, "patients": 0.3876110911369324, "rituximab": 0.3803066611289978, "drug": 0.36034294962882996, "therapy": 0.35842165350914, "dr": 0.3573184013366699, "gene therapy": 0.348463237285614, "patients aged": 0.3436412811279297, "cell therapy": 0.34122735261917114, "chronic": 0.33347636461257935, "blood": 0.29117298126220703, "abbvie": 0.27400994300842285, "imbruvica": 0.27379217743873596, "venetoclax": 0.26760420203208923, "relapsed refractory": 0.2670987844467163, "elderly patients": 0.2578878402709961, "relapsed": 0.25770848989486694, "chronic lymphocytic": 0.25114041566848755, "refractory": 0.25031495094299316, "study": 0.24977581202983856, "capsule": 0.24734646081924438, "leukemia": 0.24567028880119324, "ginsenoside rh": 0.24126151204109192, "venetoclax plus": 0.23834124207496643, "fda": 0.2370581477880478, "cancer": 0.22723986208438873, "risk": 0.22299465537071228, "results": 0.21746480464935303, "lymphocytic": 0.21375508606433868, "trial": 0.20440056920051575, "ginsenoside": 0.19212359189987183, "response": 0.1771726757287979, "long term": 0.1725350320339203, "amp nbsp": 0.1707763671875, "in": 0.16816365718841553, "with": 0.16212999820709229, "lymphocytic leukemia": 0.16020560264587402, "cells": 0.15996912121772766, "rh": 0.15865527093410492, "cell": 0.1557176113128662, "tg": 0.1543450653553009, "data": 0.15422888100147247, "as": 0.15212145447731018, "amp": 0.14958417415618896}, "1": {"lymphocytic leukemia": 0.8443622589111328, "leukemia": 0.8074296116828918, "chronic lymphocytic": 0.6471784114837646, "lymphocytic": 0.621312141418457, "cell therapy": 0.5765259861946106, "cancer": 0.5524591207504272, "gene therapy": 0.5040141940116882, "cells": 0.4306311011314392, "tg therapeutics": 0.41243743896484375, "cell": 0.4062071442604065, "clinical": 0.3328090310096741, "treatment": 0.3264293670654297, "efficacy": 0.308349609375, "therapy": 0.2893258333206177, "drug": 0.28284725546836853, "blood": 0.27515119314193726, "patients": 0.27257129549980164, "venetoclax": 0.2705126702785492, "venetoclax plus": 0.26740264892578125, "car cell": 0.25856149196624756, "chronic": 0.2527901232242584, "patients aged": 0.23017027974128723, "trial": 0.2215469479560852, "rituximab": 0.22024410963058472, "ginsenoside rh": 0.2101099193096161, "capsule": 0.18286839127540588, "ginsenoside": 0.1748371124267578, "dr": 0.1712554395198822, "elderly patients": 0.16697224974632263, "relapsed": 0.1632552146911621, "relapsed refractory": 0.15822833776474, "results": 0.14751610159873962, "refractory cll": 0.14191094040870667, "ibrutinib": 0.12679094076156616, "cll": 0.12259890884160995, "risk": 0.12165521085262299, "study": 0.1144389733672142, "tg": 0.1088024377822876, "imbruvica": 0.10843374580144882, "long term": 0.09748400002717972, "data": 0.0968148410320282, "rh": 0.08145855367183685, "fda": 0.07354254275560379, "will": 0.07096397876739502, "response": 0.062367137521505356, "jinxing capsule": 0.062108393758535385, "phase": 0.05918943136930466, "if you": 0.057057950645685196, "will be": 0.047824081033468246, "refractory": 0.03765369951725006}, "2": {"car cell": 0.6425397992134094, "cell therapy": 0.5743588209152222, "gene therapy": 0.5115062594413757, "cells": 0.4520235061645508, "leukemia": 0.43191492557525635, "tg therapeutics": 0.42112332582473755, "cancer": 0.41843360662460327, "cell": 0.4089031517505646, "blood": 0.40188199281692505, "lymphocytic leukemia": 0.39400744438171387, "chronic lymphocytic": 0.35523721575737, "lymphocytic": 0.3398284316062927, "efficacy": 0.32937127351760864, "clinical": 0.31969356536865234, "therapy": 0.30059391260147095, "car": 0.29385995864868164, "treatment": 0.29098933935165405, "refractory cll": 0.25420820713043213, "drug": 0.24215450882911682, "patients": 0.2388453483581543, "chronic": 0.2364043891429901, "capsule": 0.21719114482402802, "cll": 0.21598823368549347, "ibrutinib": 0.20825929939746857, "patients aged": 0.19372917711734772, "dr": 0.18866917490959167, "venetoclax plus": 0.18030470609664917, "risk": 0.17616049945354462, "venetoclax": 0.17403113842010498, "trial": 0.16744691133499146, "relapsed refractory": 0.1656116545200348, "relapsed": 0.15951894223690033, "study": 0.13032086193561554, "elderly patients": 0.10736410319805145, "results": 0.10570156574249268, "rituximab": 0.10562995076179504, "data": 0.09931574761867523, "response": 0.08962813019752502, "fda": 0.08554185926914215, "refractory": 0.08049751073122025, "imbruvica": 0.07536423951387405, "ginsenoside rh": 0.07200706750154495, "ginsenoside": 0.06494227051734924, "tg": 0.0643121674656868, "jinxing capsule": 0.059241510927677155, "may": 0.051653020083904266, "can": 0.04321432113647461, "long term": 0.04218935966491699, "new": 0.02716290019452572, "phase": 0.02568420022726059}, "3": {"cancer": 0.5952264666557312, "gene therapy": 0.561916708946228, "cell therapy": 0.5333501100540161, "tg therapeutics": 0.484068900346756, "clinical": 0.47330379486083984, "efficacy": 0.46579933166503906, "drug": 0.459940642118454, "treatment": 0.44310954213142395, "leukemia": 0.428997278213501, "therapy": 0.42419493198394775, "dr": 0.38200923800468445, "fda": 0.37722882628440857, "lymphocytic leukemia": 0.3769909739494324, "patients": 0.3680649399757385, "lymphocytic": 0.3521628975868225, "chronic lymphocytic": 0.3502867519855499, "trial": 0.31440675258636475, "rituximab": 0.3058233857154846, "cells": 0.30325847864151, "cell": 0.2775557041168213, "patients aged": 0.26404470205307007, "chronic": 0.2619139552116394, "venetoclax": 0.2547481060028076, "capsule": 0.24187436699867249, "blood": 0.23929853737354279, "venetoclax plus": 0.23807279765605927, "ibrutinib": 0.22476017475128174, "car cell": 0.2228517383337021, "results": 0.20206981897354126, "relapsed refractory": 0.18301570415496826, "study": 0.17713141441345215, "relapsed": 0.17306707799434662, "elderly patients": 0.16745632886886597, "ginsenoside rh": 0.16474097967147827, "risk": 0.15738292038440704, "for": 0.1468544900417328, "refractory cll": 0.13814908266067505, "rh": 0.1369345486164093, "data": 0.12705928087234497, "response": 0.11975210905075073, "refractory": 0.11222030967473984, "imbruvica": 0.10184549540281296, "first": 0.09871750324964523, "tg": 0.09543552994728088, "and": 0.0912097692489624, "with": 0.08804184198379517, "cll": 0.08699619770050049, "ginsenoside": 0.08573730289936066, "on": 0.08229976892471313, "at": 0.07746176421642303}, "4": {"venetoclax": 0.7610354423522949, "venetoclax plus": 0.7357931137084961, "refractory cll": 0.5389280319213867, "cll": 0.4529847502708435, "rituximab": 0.4496288597583771, "relapsed refractory": 0.385476291179657, "ibrutinib": 0.36644434928894043, "relapsed": 0.3597572445869446, "drug": 0.3418964743614197, "efficacy": 0.33487820625305176, "tg therapeutics": 0.3252601623535156, "refractory": 0.3187333345413208, "clinical": 0.2882445454597473, "treatment": 0.27564361691474915, "ginsenoside rh": 0.27319592237472534, "cell therapy": 0.26425182819366455, "results": 0.248001366853714, "gene therapy": 0.24329663813114166, "capsule": 0.24233487248420715, "lymphocytic": 0.23989111185073853, "leukemia": 0.2392313927412033, "therapy": 0.22662892937660217, "chronic lymphocytic": 0.2214396595954895, "lymphocytic leukemia": 0.2184811234474182, "imbruvica": 0.21386021375656128, "tg": 0.21224580705165863, "ginsenoside": 0.21180447936058044, "response": 0.20479682087898254, "blood": 0.20196887850761414, "fda": 0.19731047749519348, "abbvie": 0.1940738558769226, "trial": 0.182987242937088, "risk": 0.1815490871667862, "patients": 0.17962300777435303, "phase": 0.1767534613609314, "cell": 0.17572343349456787, "study": 0.17185205221176147, "chronic": 0.17086493968963623, "cells": 0.16946318745613098, "car cell": 0.16921451687812805, "cancer": 0.16511571407318115, "rh": 0.16259628534317017, "patients aged": 0.1574687659740448, "dr": 0.15265309810638428, "jinxing capsule": 0.14596861600875854, "amp nbsp": 0.14532698690891266, "amp": 0.14207521080970764, "has": 0.1414026916027069, "will": 0.13834239542484283, "and": 0.12778303027153015}}